Dyne therapeutics stock
WebThe Dyne Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention. WebOct 4, 2024 · Dyne Therapeutics (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, visits ...
Dyne therapeutics stock
Did you know?
WebDYN stock forecast Our latest prediction for Dyne Therapeutics Inc's stock price was made on the Dec. 15, 2024 when the stock price was at 13.59$.. In the short term (2weeks), DYN's stock price should underperform the market by -4.52%.During that period the price should oscillate between -12.37% and +6.64%.. In the medium term (3months), DYN's … WebStock analysis for Dyne Therapeutics Inc (DYN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
WebDYN Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for Dyne Therapeutics in the last 3 months. The average price target is $28.50 with a high forecast of $34.00 and a low forecast of $20.00. The average price target represents a 155.61% change from the last price of $11.15. WebStock Price Forecast. The 8 analysts offering 12-month price forecasts for Dyne Therapeutics Inc have a median target of 28.00, with a high estimate of 47.00 and a low estimate of 20.00. The median estimate represents a +199.15% increase from the last price of …
WebDyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that … WebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of …
WebStock analysis for Dyne Therapeutics Inc (DYN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
WebJan 26, 2024 · Dyne Therapeutics (DYN) reached the highest level since September as Guggenheim launched its coverage with a Buy rating citing its potential in muscular … cummins 2888182Web19 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Dyne Therapeutics (DYN) cummins 2880215WebApr 6, 2024 · 91,5%. More Financials. Company. Dyne Therapeutics Inc. is a muscle disease company. The Company is focused on advancing therapeutics for patients with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. cummins 2.8WebDec 31, 2024 · Dyne Therapeutics. (DYN) is scheduled to report earnings on March 9, 2024.The last reported earnings were for reported on November 3, 2024 for Q3. cummins 2897332WebView the latest Dyne Therapeutics Inc. (DYN) stock price, news, historical charts, analyst ratings and financial information from WSJ. cummins 2988WebThe latest price target for . Dyne Therapeutics (NASDAQ: DYN) was reported by Chardan Capital on March 3, 2024.The analyst firm set a price target for $20.00 expecting DYN to rise to within 12 ... eastwood arms niles ohioWebJan 26, 2024 · Dyne Therapeutics (DYN) reached the highest level since September as Guggenheim launched its coverage with a Buy rating citing its potential in muscular diseases. Read the full story here. cummins 2.8 repower